BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
Open accessThe DOI matches its Crossref record; 605 of the 605 references it cites were found in a registry or an index.
Abstract
The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with OUD should typically be initiated and stabilized on medications for OUD (MOUD) prior to initiating a BZD taper, and the MOUD dose should be kept stable throughout the BZD tapering process.145,146”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [146]
Citations
Cites
4 retracted
Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders
Knapp, W. P., Soares, B., Farrell, M., & Silva de Lima, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003023.pub2 · Cited by 178 · cited 1×
“NICE has undertaken several systematic reviews and meta-analyses in these areas, and there are other guidelines and Cochrane reviews available (e.g. Ferri et al., 2011; Knapp et al., 2007; White et al., 2011).”
MethodRetractedPharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
Denis, C., Fatseas, M., Lavie, E., & Auriacombe, M. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005194.pub2 · Cited by 122
RetractedTreatment for amphetamine dependence and abuse
Srisurapanont, M., Jarusuraisin, N., & Kittirattanapaiboon, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003022 · Cited by 77 · cited 1×
“No reduction in amphetamine use or other benefits were identified (Srisurapanont et al., 2001) (Ia).”
BackgroundRetractedRETRACTED ARTICLE: Acamprosate and its efficacy in treating alcohol dependent adolescents
Niederhofer, H., & Staffen, W. (2003) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-003-0327-1 · Cited by 55
RetractedRegier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · cited 2×
“For instance, anxiety disorders are associated with alcohol abuse or greater non-medical opioid use and vice versa (Martins et al., 2011; Regier et al., 1990).”
BackgroundThe size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Yatham, L., & Malhi, G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199562305.001.0001 · Cited by 3,506
Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008
(2011) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02847.x · Cited by 2,994
Systematic review and meta-analysis
(2019) · Providing Information for Health · doi:10.1201/9781315377315-19 · Cited by 2,659
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Research works printed but not linked: 39
- Amato L, 2007, Cochrane Database Syst Rev, 3
- Baillargeon L, 2003, Can Med Assoc J, 169, 1015
- Beer B, 2010, Neuropsychiatrie, 4, 108
- 10.1037/1064-1297.10.3.276 · doi:10.1037/1064-1297.10.3.276 · Paper page
- British Medical Association, Board of Science and Education, 2003, Adolescent Health
- Casas M, 2008, Actas Esp Psiquiatr, 36, 350
- Dean AJ, 2006, J Psychiatry Neurosci, 31, 38
- Di Costanzo E, 1992, Minerva Psychiatr, 33, 301
- Frischer M, 2003, Substance misuse and young people
- Gelernter J, 2007, Alcohol Clin Exp Res, 31, 555
- Lehmann WX, 1973, NIDA Res Monogr, 8, 82
- McCaul B, 1996, Alcohol Clin Exp Res, 20, 216A
- McDonough M, 2004, Drug Alcohol Depend, 75, 3
- Martins SS, 2011, Psychol Med, 17, 1
- NICE, National Institute for Health and Clinical Excellence, 2004, Zaleplon, zolpidem and zopiclone for the management of insomnia: NICE technology appraisal guidance 77
- NICE, National Institute for Health and Clinical Excellence, 2007, Antenatal and postnatal mental health. Clinical management and service guidance. NICE clinical guideline 45
- NICE, National Institute for Health and Clinical Excellence, 2007, Drug misuse: opiate detoxification management of drug misusers in the community and prison settings. NICE clinical guideline 57
- NICE, National Institute for Health and Clinical Excellence, 2007, Methadone and buprenorphine for the management of opioid dependence: NICE technology appraisal guidance 114
- NICE, National Institute for Health and Clinical Excellence, 2007, Naltrexone for the management of opioid dependence: NICE technology appraisal guidance 115
- NICE, National Institute for Health and Clinical Excellence, 2007, Varenicline for smoking cessation: NICE technology appraisal guidance 123
- NICE, National Institute for Health and Clinical Excellence, 2010, How to stop smoking in pregnancy and following childbirth. NICE public health guidance 26
- NICE, National Institute for Health and Clinical Excellence, 2010, Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors. NICE clinical guideline 110
- NICE, National Institute for Health and Clinical Excellence, 2010, Alcohol-use disorder: physical complications. NICE clinical guideline 100
- NICE, National Institute for Health and Clinical Excellence, 2011, Alcohol dependence and harmful alcohol use. NICE clinical guideline 115
- NICE, National Institute for Health and Clinical Excellence, 2011, Psychosis with coexisting substance misuse. NICE clinical guideline 120
- National Treatment Agency and Department of Health, 2010, Statistics from the National Alcohol Treatment Monitoring System (NATMS) 1st April 2008 – 31st March 2009
- National Treatment Agency and Department of Health, 2010, Statistics from the National Drug Treatment Monitoring System (NDTMS) 1st April 2009 – 31st March 2010
- O’Brien CP, 2011, Am J Addict, 20, 106
- 10.1111/j.1530-0277.2000.tb04648.x · doi:10.1111/j.1530-0277.2000.tb04648.x · Paper page
- Reay G, 2009, An Inquiry into Physical Dependence and Addiction to Prescription and Over-the-Counter Medication
- Reed K, 2011, The Changing Use of Prescribed Benzodiazepines and Z-Drugs and of Over-The-Counter Codeine-Containing Products in England: a Structured Review of Published English and International Evidence and Available Data to Inform Consideration of the Extent of Dependence and Harm
- Smeerdijk M, 2011, Psychol Med, 8, 1
- 10.1037/1064-1297.10.3.241 · doi:10.1037/1064-1297.10.3.241 · Paper page
- TIP, Treatment Improvement Protocol Series 45, 2006, Detoxification and Substance Abuse Treatment
- TIP, Treatment Improvement Protocol Series 49, 2009, Incorporating Alcohol Pharmacotherapies Into Medical Practice
- USDHHS, 2008, US Department of Health and Human Services. Treating Tobacco Use and Dependence: 2008 Update of Clinical Practice Guideline
- van den Brink W, 2012, Curr Drug Abuse Rev
- van der Meer RM, 2001, Cochrane Database Syst Rev, 1
- Vornik LA, 2006, J Clin Psychiatry, 67, 24
Cited by
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Baldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“…Consensus Group of British Association for Psychopharmacology, 2011; Burns and O’Brien., 2006; Goodwin, 2003, 2005; Goodwin et al., 2008; Lingford-Hughes et al., 2004, 2012; National Institute for Health and Clinical Excellence, 2011; O’Brien and Burns, 2010; Nutt et al., 2006; Wilson…”
BackgroundSelf-citationThe dopamine theory of addiction: 40 years of highs and lows
Nutt, D. J., Lingford-Hughes, A., Erritzoe, D., & Stokes, P. R. A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3939 · Cited by 649
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationTreatment of Benzodiazepine Dependence
Soyka, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1611832 · Cited by 465
Metadata
- Authors
- Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N.
- Affiliations
- Imperial College London, CNWL NHS Foundation Trust, London, UK
- Gether NHS Foundation Trust, Gloucester, UK
- Pennine Care NHS Foundation Trust (GB)
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2012-05-23
- Volume
- 26
- Issue
- 7
- Pages
- 899-952
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2164638855
- Cited by
- 332
- References
- 604
- Citations by year
- 2026: 16 · 2025: 10 · 2024: 23 · 2023: 12 · 2022: 13 · 2021: 33 · 2020: 52 · 2019: 28 · 2018: 23 · 2017: 23 · 2016: 35 · 2015: 21 · 2014: 22 · 2013: 15 · 2012: 6
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Pfizer
- Reckitt Benckiser Pharmaceuticals
- Cancer Research UK (14135)
- H. Lundbeck A/S
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Social Sciences › Psychology › Clinical Psychology › Gambling Behavior and Treatments
- Keywords
- substance abuse, addiction, pharmacological management, withdrawal, replacement therapy, abstinence maintenance, psychiatric comorbidity, pregnancy, older adults, youth
- MeSH terms
- Adolescent, Adult, Aged, Mental Disorders, Child, Combined Modality Therapy, Female, United Kingdom, Humans, Male, Pregnancy, Pregnancy Complications, Psychotherapy, Substance Withdrawal Syndrome, Comorbidity, Evidence-Based Medicine, Substance-Related Disorders, Diagnostic and Statistical Manual of Mental Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. https://app.cochat.ai/papers/10.1177/0269881112444324
- The paper
- Lingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012). BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. Journal of Psychopharmacology. https://doi.org/10.1177/0269881112444324
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.